Management of fungal infection

Similar documents
Antifungal drugs Dr. Raz Muhammed

Pathogens with Intermediate Virulence Dermatophytes opportunistic Pathogens

Common Fungi. Catherine Diamond MD MPH

Rheem Totah, Office H172M, Ph Office hours MWF 11:30 12:20 or by arrangement

Dr Hamed Alzoubi. Fungal infections

number Done by Corrected by Doctor

Fungi are eukaryotic With rigid cell walls composed largely of chitin rather than peptidoglycan (a characteristic component of most bacterial cell

Fungi. Eucaryotic Rigid cell wall(chitin, glucan) Cell membrane ergosterol Unicellular, multicellular Classic fungus taxonomy:

number Done by Corrected by Doctor

Mycology. BioV 400. Clinical classification. Clinical classification. Fungi as Infectious Agents. Thermal dimorphism. Handout 6

Introduction Medical Mycology. Prof. Dr. Asem Shehabi Faculty of Medicine University of Jordan

Bloodborne Pathogens. Introduction to Fungi. Next >> COURSE 2 MODULE 4

Opportunistic Mycoses

All three dermatophytes contain virulence factors that allow them to invade the skin, hair, and nails. Keratinases. Elastase.

Antifungal Agents. Polyenes Azoles Allyl and Benzyl Amines Other antifungals

Antimycotics. November 14, Jan Strojil. Ústav farmakologie LF UP

Med Chem 401: Mycology ( Mycology

Ali Alabbadi. Sarah Jaar ... Nader

Nursing college, Second stage Microbiology Dr.Nada Khazal K. Hendi Medical Microbiology

Antifungal therapies differences in agents

Deep Dermatophytosis

number Done by Corrected by Doctor د.حامد الزعبي

Introduction. Study of fungi called mycology.

Use of Antifungals in the Year 2008

About the Editor Gerri S. Hall, Ph.D.

ABDUL AZIZ ALSHAMALI

Dermatophytes Dr. Hala Al Daghistani

Fungal biology. Fungal Infections. Fungal cell structure. Pathogenesis

Fungal biology. Pathogenesis. Fungal cell structure. Fungal Infections MID 25 & 26. Eukaryotic (organized nucleus and cell structure) Non-motile

LUZU (luliconazole) external cream

To Order, Visit the Purchasing Page for Details

1. Multiple choice (30 2 each); circle the number of the correct choice. b. Trichophyton schoenleinii is traditionally most associated with

Epidemiology and ecology of fungal diseases

Fungal update. Liise-anne Pirofski, M.D. Albert Einstein College of Medicine

Classification. Distal & Lateral Subungual OM. White Superficial OM. Proximal Subungual OM. Candidal OM. Total dystrophic OM

A class IIa medical device intended for mild-to-moderate fungal nail infection PRODUCT MONOGRAPH

Itraconazole DIGICON. Composition: MOLECULAR INTRODUCTION

Prophylaxis versus Diagnostics-driven approaches to treatment of Invasive fungal diseases. Y.L. Kwong Department of Medicine University of Hong Kong

Medical Mycology. Dr. Hala Al Daghistani

TINEA (FUNGAL) INFECTION

Outline Dermatomycoses Definition: diseases or fungal infections of the skin Transmission of Dermatomycoses Case Report 1 Presentation of Disease

ANTIMYCOTIC DRUGS Modes of Action

PROGRESSI NELLA TERAPIA ANTIFUNGINA. A tribute to Piero Martino

Malaria prevention: source = The Sanford Guide to Antimicrobial Therapy. Gilbert et al.

Types of fungi Diseases that can be caused by filamentous fungi or yeast which can cause: Aspergillusis-mold infection Micro conidia Microspore

Fungal infection in the immunocompromised patient. Dr Kirsty Dodgson

Antifungal Agents. Prof. Suheil Zmeili Faculty of Medicine Department of Pharmacology University of Jordan

DISEASES OF FUNGAL ORIGIN

Summary of the risk management plan (RMP) for Cresemba (isavuconazole)

Catamaran Prior Authorization Department. Phone: Fax: Prescriber Information. Member Information.

Mycology. Dr. Agoston Ghidan

Voriconazole October 2015 Risk Management Plan. Voriconazole

Drugs dermatological conditions II

Use of Antifungal Drugs in the Year 2006"

MERCY RETREAT Dermatology

Prevalence of Nondermatophytes in Clinically Diagnosed Taeniasis

Course content. Chemotherapeutic agents

Elements for a Public Summary. [Product Name] 40 mg/ml oral suspension. VI.2.1 Overview of disease epidemiology

PHARMACEUTICAL CHEMISTRY II (PHCM672) Lecture 1, Antifungal Drugs (Antimycotics) Dr. Mohammad Abdel-Halim

Second Joint Conference 0f the British HIV Association [BHIVA] and the British Association for Sexual Health and HIV [BASHH]

Case. Fungal infections for the community provider. Case. Case. April 25, 2014 Peter V. Chin-Hong M.D. Infectious Diseases UCSF UCSF

Fungal infections in ICU. Tang Swee Fong Department of Paediatrics Universiti Kebangsaan Malaysia

Medical Mycology. Dr. Hala Al Daghistani

ECMM Excellence Centers Quality Audit

THE TREATMENT OF MYCOSES IN REPTILES: A REVIEW OF ANTIFUNGAL DRUGS

Common Superficial Fungal Infections

Fungi. CLS 311 Mrs. Ohoud alhumaidan

Isolation and Identification of Dermatophytes from Clinical Samples One Year Study

IJBCP International Journal of Basic & Clinical Pharmacology

Cigna Drug and Biologic Coverage Policy

Dermatophyte abscesses caused by Trichophyton rubrum in a patient without pre-existing superficial dermatophytosis: a case report

Pharmaceutical Chemistry II. Antifungal Agents. = Antimycotics. Tutorial 1

Update from the Laboratory: Clinical Identification and Susceptibility Testing of Fungi and Trends in Antifungal Resistance 13

Clinical Practice Guideline Superficial Fungal Infection

How Can We Prevent Invasive Fungal Disease?

FLUCAND HIKMA PHARMACEUTICALS

DRUGS TO FIGHT AGAINST MICROORGANISMS. Fungi, Viruses, Protozoa, & Helminths Chapter s 42 & 43

Mycotic Infections. A. The fungi represent a diverse, heterogeneous group of eukaryotic

See Important Reminder at the end of this policy for important regulatory and legal information.

Antifungal Agents - Cresemba (isavuconazonium), Vfend. Prior Authorization Program Summary

Title: Author: Speciality / Division: Directorate:

HAEMATOLOGY ANTIFUNGAL POLICY

Abstract. OBJECTIVE--To compare the efficacy and safety of terbinafine 1% cream and clotrimazole 1% cream in the treatment of tinea pedis.

Clinical Policy: Itraconazole (Onmel, Sporanox) Reference Number: ERX.NPA.25 Effective Date:

Antifungal treatment of severe asthma

See Important Reminder at the end of this policy for important regulatory and legal information.

Fungal Infections. Alessandro Diana November 22th 2007

Fungal infections and critically ill adults

Introduction. Yeast candida, cryptococcus, trichosporon. Filamentous rhizopus, rhizomucor, mucor. Dimorphic Fungi bl t hi t l

MANAGEMENT OF HOSPITAL-ACQUIRED FUNGAL INFECTIONS

Summary of Product Characteristics

Iraqi JMS. Israa A. Ali PhD. Abstract. Background. Objective Methods. Results. Conclusion. Keywords Citation

Case Studies in Fungal Infections and Antifungal Therapy

Medical Bulletin. Introduction. Diseases Caused by Dermatophytes

Antimicrobials; antibacterials, antifungals, antiprotozoans, antivirals, and antihelminthics 6

Fungi More or Less Obligately Associated with Humans. Requirements for Designating a Mycosis*

For the use only of Registered Medical Practitioners or a Hospital or a Laboratory ZODERM E CREAM. Oxiconazole Nitrate Cream

Candida albicans. Habitat, Morphology, Cultural Characteristics, Life Cycle, Pathogenesis, Lab Diagnosis, Treatments, Prevention and Control

MEDICAL MYCOLOGY Fungi

Transcription:

Management of fungal infection HKDU symposium 17 th May 2015 Speaker: Dr. Thomas Chan MBBS (Hons), MRCP, FHKCP, FHKAM

Synopsis Infection caused by fungus mycoses Skin infection by fungus is common in general practice Infection of other sites less common when compared to bacterial infection Opportunists: invasive infection occurs often in immunocompromised host

Classification of fungal infection Yeast versus moulds - Yeast: Candida, Cryptococcus - Moulds: Aspergillus, Mucorales - Dimorphic fungi: Penicillium Marneffei Superficial versus deep - cutaneous infection - deep seated infection (invasive mycoses)

Examples of superficial mycoses Most often cauesed by candida and dermatophytes (Trichophyton, Epidermophyton, Microsporum) Usually cause nuisance but not life-threatening

Oropharyngeal candidiasis Also called oral thrush Common in infant and elderly Predisposing factors: - diabetes mellitus - xerostomia - dentures - antibiotics - weaked immunity (e.g. inhaled steroid therapy)

Oropharyngeal candidiasis Two clinical forms: - pseudomembranous form - atrophic form

Oropharyngeal candidiasis: pseudomembranous form

Oropharyngeal candidiasis: atrophic form

Oropharyngeal candidiasis Diagnosis is made by swab and KOH preparation Presence of budding yeast with or without pseudohyphae formation under microscopy Clinical diagnosis in most of the time

Treatment Nystatin solution swish and swallow 600000units QID for 7-14 days Fluconazole 200mg x 1 then 100m daily for 7-14 days Watch out for esophageal involvement

Vulvovaginal candidiasis Predisposing factors include diabetes, antibiotics use and high estrogen state Various topical preparations (cream and pessary) are available for treatment

Dermatophytosis (Tinea) Terminology depends on sites of involvement - Tinea capitis: infection of the scalp - Tinea pedis: athlete s foot - Tinea corporis: infection of the skin of trunk - Tinea cruris: infection of the crural folds - Tinea unguium: infection of the nails

Dermatophytosis (Tinea)

Dermatophytosis (Tinea)

Dermatophytosis (Tinea)

Dermatophytosis (Tinea)

Dermatophytosis (Tinea)

Dermatophytosis (Tinea)

Dermatophytosis (Tinea)

Dermatophytosis (Tinea) Topical antifungals suffice for majority of skin infection except tinea capitis Tinea capitis requires systemic antifungals (Griseofulvin, terbinafine or azoles) Tinea unguium requires systemic antifungals (Terbinafine, azoles like itraconazole) The duration of treatment for tinea unguium is 6-12 weeks

Deep mycoses Often occur in in-patient setting Complications of a weakened immunity High morbidity and high mortality

Deep mycoses Examples of deep mycoses include: - invasive aspergillosis - cryptococcosis - mucormycosis

Mucormycosis Mucorales causes most infection (Rhizopus spp., Mucor spp.) Rhinocerebral mucormycosis Pulmonary mucormycosis Gastrointestinal mucormycosis

Mucormycosis Rhizopus thrive in acidic environment with high glucose concentration Diabetes being an important risk factor for development of infection Most commonly rhinocerebral mucormycosis

Rhinocerebral mucormycosis Symptoms commonly include fever, facial pain, facial numbness, visual blurring and diplopia. Look for eschar in the hard palate In the setting of underlying predisposing factors: organ or stem cell transplant, AIDS, diabetes mellitus

Rhinocerebral mucormycosis O Neill BM, et al. J Oral Maxillofac Surg (2006) 64:326-333

Rhinocerebral mucormycosis Treatment involves systemic antifungal therapy (amphotericin B or posaconazole) and surgical debridement, which is often extensive

Rhinocerebral mucormycosis O Neill BM, et al. J Oral Maxillofac Surg (2006) 64:326-333

Rhinocerebral mucormycosis Be aware of symptoms that might hint towards the diagnosis of mucormycosis in patients with diabetes. It is a rare condition, but can kill

Gastrointestinal mucormycosis Lo OSH, et al. World J Gastroenterol 2010; 16(9): 1165-1170

Aspergillosis Most common site of infection: lung Pulmonary aspergillosis is an important complication in patients with haematological malignancy Early diagnosis is critical Treatment involve use of systemic antifungal, voriconazole would be the preferred choice Amphotericin B/liposomal amphotericin B if there is contraindication

Aspergillosis

Recapitulation Mycoses are often opportunistic infection Cutaneous infection is common in general practice Different forms of cutaneous fungal infection Deep mycoses and their relevance to general practice

~ The End ~